Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|September 5, 2012
Psychological outcomes of familial ovarian cancer screening: no evidence of long-term harmKate E Brain, Kate J Lifford, Lindsay Fraser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2013
Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancerS T Ligthart, F-C Bidard, C Decraene, et al.
Clinical Endocrinology|January 17, 2007
Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasiaLin Lin, Peter C Hindmarsh, Louise A Metherell, et al.
British Journal of Cancer|January 1, 1997
Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapyE Brain, C Garrino, J L Misset, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patientsA Yovine, M Riofrio, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II studyI Monnet, Cremoux H de, P Soulié, et al.
Journal of Alzheimer'S Disease : JAD|November 25, 2017
Hippocampal Stratum Radiatum, Lacunosum, and Moleculare Sparing in Mild Cognitive ImpairmentLi Su, Lawrence Hayes, Soteris Soteriades, et al.
Breast Cancer Research and Treatment|September 6, 2019
Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie databaseE Kaczmarek, C Saint-Martin, J-Y Pierga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2020
Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆F Montemurro, S Delaloge, C H Barrios, et al.
Gynecologic Oncology|October 18, 2011
Withdrawal from familial ovarian cancer screening for surgery: findings from a psychological evaluation study (PsyFOCS)Kate J Lifford, Lindsay Fraser, Adam N Rosenthal, et al.
Pageof 11